TGF-β1 induces mouse dendritic cells to express VEGF and its receptor (Flt-1) under hypoxic conditions
Open Access
- 1 January 2010
- journal article
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 42 (9) , 606-613
Abstract
Experimental & Molecular Medicine is an open access journal that publishes the highest quality articles in translational research and biomedical studies.Keywords
This publication has 28 references indexed in Scilit:
- The Role of Vascular Endothelial Growth Factor in Wound HealingJournal of Surgical Research, 2009
- Transforming Growth Factor β-1 Induces Snail Transcription Factor in Epithelial Cell LinesJournal of Biological Chemistry, 2003
- Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathwayOncogene, 2003
- Cutting Edge: Differential Chemokine Production by Myeloid and Plasmacytoid Dendritic CellsThe Journal of Immunology, 2002
- Interleukin‐1α (IL‐1α) promotes angiogenesis in vivo via VEGFR‐2 pathway by inducing inflammatory cell VEGF synthesis and secretionThe FASEB Journal, 2002
- Transforming growth factor‐β and Ras regulate the VEGF/VEGF‐receptor system during tumor angiogenesisInternational Journal of Cancer, 2001
- Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor DegradationJournal of Biological Chemistry, 2001
- Stabilization of Vascular Endothelial Growth Factor mRNA by Hypoxia and Hypoglycemia and Coregulation with Other Ischemia-Induced GenesMolecular and Cellular Biology, 1995
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Transforming growth factor-beta: Potential common mechanisms mediating its effects on embryogenesis, inflammation-repair, and carcinogehesisInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1987